We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Diagnostic Microchip Inserted Under Skin Can Detect COVID-19

By LabMedica International staff writers
Posted on 14 Apr 2021
Print article
Image: Diagnostic Microchip Inserted Under Skin Can Detect COVID-19 (Photo courtesy of DARPA)
Image: Diagnostic Microchip Inserted Under Skin Can Detect COVID-19 (Photo courtesy of DARPA)
Researchers have created a microchip that can detect COVID-19 when inserted under the skin.

The implantable microchip developed by medical researchers at the US Pentagon’s Defense Advanced Research Projects Agency (DARPA; Arlington, VA, USA) can monitor the human body for signs of the SARS-CoV-2 virus. Details of the revolutionary technology were shared on the 60 Minutes Show by Matthew Hepburn, an infectious disease physician and retired Army colonel who is heading DARPA’s response to the pandemic.

Hepburn told CBS that the microchip, embedded in a tissue-like gel, would continuously test the chip recipient’s blood for presence of the coronavirus. Upon detecting COVID-19, the chip would alert the patient to conduct a self-administered rapid blood test to confirm the positive result. According to Hepburn, DARPA had also developed a filter to remove the SARS-CoV-2 virus from the blood through a dialysis machine. The filter had been approved by the US Food and Drug Administration (FDA) and had already been used on 300 patients. Additionally, Hepburn compared the diagnostic microchip to a car’s “Check engine” alert and assured that DARPA’s chip would neither “track your every move” nor be administered via vaccines.

“It’s a sensor,” Hepburn told CBS. “That tiny green thing in there, you put it underneath your skin and what that tells you is that there are chemical reactions going on inside the body and that signal means you are going to have symptoms tomorrow. We can have that information in three to five minutes. As you truncate that time, as you diagnose and treat, what you do is you stop the infection in its tracks.”

Related Links:
Defense Advanced Research Projects Agency (DARPA)

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.